HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nuria Rubio |
| Publication date | December 1, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |